Doctors & patients are saying about 'A-Fib.com'...
"A-Fib.com is a great web site for patients, that is unequaled by anything else out there."
Dr. Douglas L. Packer, MD, FHRS, Mayo Clinic, Rochester, MN
"Jill and I put you and your work in our prayers every night. What you do to help people through this [A-Fib] process is really incredible."
Jill and Steve Douglas, East Troy, WI
“I really appreciate all the information on your website as it allows me to be a better informed patient and to know what questions to ask my EP.
Faye Spencer, Boise, ID, April 2017
“I think your site has helped a lot of patients.”Dr. Hugh G. Calkins, MD Johns Hopkins,
Baltimore, MD
2021 AF Symposium: 5 New Summary Reports Posted
I’ve completed several new reports on presentations made at the 2021 AF Symposium. With each report, I strive to share the current state of the art in A-Fib research and treatments and what’s relevant to patients with Atrial Fibrillation. Symposium presenters are the best clinicians and researchers working in Atrial Fibrillation today. My new reports include:
Two Spotlight Sessions on New Technologies/Drugs: A new antiarrhythmic drug in development, and an inhaler that delivers Flecainide for fast results.
Two Clinical Trials: Results comparing the effectiveness of CryoBalloon ablation vs. Drug Therapy; and Findings from the ATTEST trial.
Research: The role of anticoagulants in A-Fib patients who develop cognitive impairment, cerebral microbleeds and dementia entitled “Cerebral Amyloid Angiopathy (CAA).
The new reports (with links):
• Spotlight Session: New Technologies and Drugs―Flecainide Inhaler by InCarda Therapeutics
• Spotlight Session: Drug in Development from Acesion Pharma
• Anticoagulants and Cerebral Amyloid Angiopathy (CAA): Prevalence, Detection and Management
• ATTEST Trial: Catheter Ablation to Modify Progression of AF
• Another Study Finds Ablation Better First-Line Treatment Than Medication
Look for more of my reports from the 2021 AF Symposium in the next weeks and months. And, as always, my reports are written in plain language for A-Fib patients and their families.
Go to my list of all 2021 AF Symposium Reports
